SCHEMBL17485405

SCHEMBL17485405

Cc1nc2c(F)cc(-c3nc(Nc4ccc(N5CCC(N(C)C)CC5)nn4)ncc3F)cc2n1C(C)C

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 19/20 0.60
CDK6 Q00534 16/20 0.60
CDK2 P24941 14/20 0.60
CDK1 P06493 12/20 0.58
CDK7 P50613 7/20 0.58
CDK9 P50750 7/20 0.58
CCNB1 P14635 8/20 0.57
CCNE1 P24864 8/20 0.57
CCND3 P30281 3/20 0.57
CCNT1 O60563 2/20 0.57
EGFR P00533 2/20 0.57
NTRK1 P04629 2/20 0.57
BRAF P15056 2/20 0.57
CCNA2 P20248 2/20 0.57
KDR P35968 2/20 0.57
MAPK8 P45983 2/20 0.57
CCNH P51946 2/20 0.57
MNAT1 P51948 2/20 0.57
MAPK10 P53779 2/20 0.57
CDK5 Q00535 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17488828 0.89 CDK4 (0.69) CDK4CDK6CDK2CDK1CDK7
SCHEMBL17485302 0.88 CDK4 (0.65) CDK4CDK6CDK2CDK1CDK7
SCHEMBL17477154 0.87 CDK6 (0.71) CDK4CDK6CDK2CDK1CDK7
SCHEMBL17477153 0.87 CDK6 (0.71) CDK4CDK6CDK2CDK1CDK7
SCHEMBL17477176 0.87 CDK6 (0.71) CDK4CDK6CDK2CDK1CDK7
SCHEMBL30926572 0.87 CDK6 (0.71) CDK4CDK6CDK2CDK1CDK7
SCHEMBL17485362 0.86 CDK4 (0.59) CDK4CDK6CDK2CDK1CDK7
SCHEMBL17485316 0.86 CDK4 (0.74) CDK4CDK6CDK2CDK1CDK7
SCHEMBL17485395 0.86 CDK4 (0.59) CDK4CDK6CDK2CDK1CDK7
SCHEMBL17488770 0.85 CDK4 (0.64) CDK4CDK6CDK2CDK1CDK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016015604-A1 COMPOUNDS AS CDK SMALL-MOLECULE INHIBITORS AND USES THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2016-02-04 WO disclosed